A Case of Acute Pancreatitis and Severe Hypertriglyceridemia Associated with Clozapine
作者： Hye Kyeong Park , Hye Jin Won , Hyo Seung Ahn , Ban Suk Lee , Seung Gu Kim
DOI: 10.3803/JKES.2007.22.5.381
关键词: Hypertriglyceridemia 、 Medicine 、 Pancreatitis 、 Atypical antipsychotic 、 Internal medicine 、 Anesthesia 、 Acute pancreatitis 、 Gastroenterology 、 Severe hypertriglyceridemia 、 Abdominal pain 、 Clozapine 、 Schizophrenia
摘要: Clozapine, an atypical antipsychotic agent, has been linked to several cases of acute pancreatitis and hypertriglyceridemia. However, neither nor hypertriglyceridemia associated with clozapine yet reported in the Republic Korea. Based on recent experience, we report a case severe clozapine. A 37-year-old schizophrenic woman good physical condition presented abdominal pain onset. She had taking for 20 months control her schizophrenia. On admission, serum triglyceride level was 6,670 mg/dL. Elevated amylase lipase levels, as well computed tomography findings, were compatible pancreatitis. After discontinuing use clozapine, normalized resolved.
koreascience.or.kr参考文章(20)
Havel Rj, Pathogenesis, differentiation and management of hypertriglyceridemia. Advances in internal medicine. ,vol. 15, pp. 117- ,(1969)
Trino Baptista, Anny Lacruz, Teraiza Meza, Quilianio Contreras, Carlos Delgado, Maria A Mejìas, Luis Hernàndez, Antipsychotic drugs and obesity: is prolactin involved? The Canadian Journal of Psychiatry. ,vol. 46, pp. 829- 834 ,(2001) , 10.1177/070674370104600906
M R Fortson, S N Freedman, P D Webster rd, Clinical assessment of hyperlipidemic pancreatitis The American Journal of Gastroenterology. ,vol. 90, pp. 2134- 2139 ,(1995)
Anil R Balani, James H Grendell, Drug-induced pancreatitis : incidence, management and prevention. Drug Safety. ,vol. 31, pp. 823- 837 ,(2008) , 10.2165/00002018-200831100-00002
P. Garlipp, O. Rosenthal, H. Haltenhof, W. Machleidt, The development of a clinical syndrome of asymptomatic pancreatitis and eosinophilia after treatment with clozapine in schizophrenia: implications for clinical care, recognition and management. Journal of Psychopharmacology. ,vol. 16, pp. 399- 400 ,(2002) , 10.1177/026988110201600419
Donna A. Wirshing, Brad J. Spellberg, Stephen M. Erhart, Stephen R. Marder, William C. Wirshing, Novel antipsychotics and new onset diabetes Biological Psychiatry. ,vol. 44, pp. 778- 783 ,(1998) , 10.1016/S0006-3223(98)00100-0
Jonathan M. Meyer, Novel Antipsychotics and Severe Hyperlipidemia Journal of Clinical Psychopharmacology. ,vol. 21, pp. 369- 374 ,(2001) , 10.1097/00004714-200108000-00003
Ananth N. Kumar, David E. Schwartz, Kaiser G. Lim, Propofol-induced pancreatitis : Recurrence of pancreatitis after rechallenge Chest. ,vol. 115, pp. 1198- 1199 ,(1999) , 10.1378/CHEST.115.4.1198
Elizabeth A. Koller, James T. Cross, P. Murali Doraiswamy, Saul N. Malozowski, Pancreatitis Associated with Atypical Antipsychotics: From the Food and Drug Administration’s MedWatch Surveillance System and Published Reports Pharmacotherapy. ,vol. 23, pp. 1123- 1130 ,(2003) , 10.1592/PHCO.23.10.1123.32759
Muharrem Keskin, Yildiran Songür, Mehmet Işler, Clomiphene-Induced Acute Pancreatitis without Hypertriglyceridemia The American Journal of the Medical Sciences. ,vol. 333, pp. 194- 196 ,(2007) , 10.1097/MAJ.0B013E3180318DA1